TP53 and cancer: Subsequent survival analysis revealed significantly worse prognoses for HCC patients in m6Acluster B compared to those in m6Acluster A. Additionally, we observed that cluster-specific DEGs were also associated with cell cycle and metabolic pathways, as well as cancer-related pathways, such as ECM-receptor interaction and p53 signaling pathway.